Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Restructuring Charges (Details)

v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies - Restructuring Charges (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2022
Protein Sciences [Member] | QT Holdings Corporation [Member]          
Accrued restructuring actions balances $ 121 $ 1,247      
Restructuring costs     $ 2,170    
Cash payments (130) (1,015) (851)    
Adjustments 18 (111) (72)    
Accrued restructuring actions balances 9 121 1,247    
Diagnostics and Genomics [Member]          
Restructuring costs       $ 1,185 $ 242
Cash payments         (1,143)
Adjustments         (284)
Selling, General and Administrative Expenses [Member] | Protein Sciences [Member] | QT Holdings Corporation [Member]          
Restructuring costs     2,170    
Selling, General and Administrative Expenses [Member] | Diagnostics and Genomics [Member]          
Restructuring costs         1,399
Employee Severance [Member] | Protein Sciences [Member]          
Accrued restructuring actions balances 604        
Restructuring costs     780    
Cash payments (586) (176)      
Adjustments (18)        
Accrued restructuring actions balances   604      
Employee Severance [Member] | Protein Sciences [Member] | QT Holdings Corporation [Member]          
Accrued restructuring actions balances 117 908      
Restructuring costs     1,328    
Cash payments (60) (753) (420)    
Adjustments (57) (38)      
Accrued restructuring actions balances   117 908    
Employee Severance [Member] | Diagnostics and Genomics [Member]          
Restructuring costs       639  
Cash payments         (589)
Adjustments         (50)
Employee Severance [Member] | Selling, General and Administrative Expenses [Member] | Protein Sciences [Member] | QT Holdings Corporation [Member]          
Restructuring costs     1,328    
Employee Severance [Member] | Selling, General and Administrative Expenses [Member] | Diagnostics and Genomics [Member]          
Restructuring costs         649
Asset Impairment and Other [Member] | Protein Sciences [Member] | QT Holdings Corporation [Member]          
Accrued restructuring actions balances 4 339      
Restructuring costs     842    
Cash payments (70) (262) (431)    
Adjustments 75 (73) (72)    
Accrued restructuring actions balances $ 9 $ 4 339    
Asset Impairment and Other [Member] | Diagnostics and Genomics [Member]          
Restructuring costs       $ 546 242
Cash payments         (554)
Adjustments         (234)
Asset Impairment and Other [Member] | Selling, General and Administrative Expenses [Member] | Protein Sciences [Member] | QT Holdings Corporation [Member]          
Restructuring costs     $ 842    
Asset Impairment and Other [Member] | Selling, General and Administrative Expenses [Member] | Diagnostics and Genomics [Member]          
Restructuring costs         $ 750